Historical record - last NADAC effective date: 6/19/2024
Product Information
MUCINEX NIGHTSHFT SEVR CLD-FLU is a brand product labeled by RB Health (US) LLC, priced at $0.0623 per ML under NDC 63824050466. Its NADAC has been published 92 times since Feb 17, 2021.
MUCINEX NIGHTSHFT SEVR CLD-FLU
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDEStrength
650; 20; 10; 2.5 mg/20mL; mg/20mL; mg/20mL; mg/20mL
Manufacturer
RB Health (US) LLCNDC
63824050466
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/1/2020
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX NIGHTSHFT SEVR CLD-FLU has been published 92 times since Feb 17, 2021, and over the history we have for it it has risen 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0623 per ML |
|---|---|
| All-time high | $0.0644 (Jun 29, 2022) |
| All-time low | $0.0512 (Feb 17, 2021) |
| Median price | $0.0571 |
| Average price | $0.0571 |
| Largest weekly change | +12.7% (Apr 6, 2022) |
| Weeks tracked | 92 |
| Tracking since | Feb 17, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-3.3%
5Y
+9.8%
All
+21.9%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
RB Health (US) LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCINEX NIGHTSHFT SEVR CLD-FLU?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX NIGHTSHFT SEVR CLD-FLU, manufactured by RB Health (US) LLC, is $0.0623 per ML (NDC 63824050466), effective Jul 3, 2024.
How has the price of MUCINEX NIGHTSHFT SEVR CLD-FLU changed over time?
Over the history we have for it, the NADAC for MUCINEX NIGHTSHFT SEVR CLD-FLU has risen 21.9%. It has been tracked across 92 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for MUCINEX NIGHTSHFT SEVR CLD-FLU?
Since Feb 17, 2021, the NADAC for MUCINEX NIGHTSHFT SEVR CLD-FLU has ranged from a low of $0.0512 (Feb 17, 2021) to a high of $0.0644 (Jun 29, 2022), with a median of $0.0571 per ML.
Are there cheaper alternatives to MUCINEX NIGHTSHFT SEVR CLD-FLU?
No other NADAC-published product currently shares the active ingredient and strength of MUCINEX NIGHTSHFT SEVR CLD-FLU in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MUCINEX NIGHTSHFT SEVR CLD-FLU?
MUCINEX NIGHTSHFT SEVR CLD-FLU (NDC 63824050466) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.